JPWO2020179797A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020179797A5 JPWO2020179797A5 JP2021504119A JP2021504119A JPWO2020179797A5 JP WO2020179797 A5 JPWO2020179797 A5 JP WO2020179797A5 JP 2021504119 A JP2021504119 A JP 2021504119A JP 2021504119 A JP2021504119 A JP 2021504119A JP WO2020179797 A5 JPWO2020179797 A5 JP WO2020179797A5
- Authority
- JP
- Japan
- Prior art keywords
- influenza
- split vaccine
- split
- producing
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019038662 | 2019-03-04 | ||
| JP2019038662 | 2019-03-04 | ||
| PCT/JP2020/008974 WO2020179797A1 (ja) | 2019-03-04 | 2020-03-03 | インフルエンザｈａスプリットワクチンの製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020179797A1 JPWO2020179797A1 (https=) | 2020-09-10 |
| JPWO2020179797A5 true JPWO2020179797A5 (https=) | 2023-08-03 |
| JP7545955B2 JP7545955B2 (ja) | 2024-09-05 |
Family
ID=72337458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021504119A Active JP7545955B2 (ja) | 2019-03-04 | 2020-03-03 | インフルエンザｈａスプリットワクチンの製造方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US12491240B2 (https=) |
| EP (1) | EP3936147A4 (https=) |
| JP (1) | JP7545955B2 (https=) |
| KR (1) | KR20210135261A (https=) |
| CN (1) | CN114096273B (https=) |
| AU (1) | AU2020233456B2 (https=) |
| BR (1) | BR112021017310A8 (https=) |
| CA (1) | CA3132578A1 (https=) |
| EA (1) | EA202192398A1 (https=) |
| IL (1) | IL285984A (https=) |
| MX (1) | MX2021010685A (https=) |
| MY (1) | MY208974A (https=) |
| PH (1) | PH12021552094A1 (https=) |
| SG (1) | SG11202109566XA (https=) |
| WO (1) | WO2020179797A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3107409A1 (en) | 2018-07-23 | 2020-01-30 | Japan As Represented By Director General Of National Institute Of Infectious Diseases | Composition containing influenza vaccine |
| KR20220098370A (ko) * | 2019-11-07 | 2022-07-12 | 세퀴러스 유케이 리미티드 | 감소된 입자 크기를 가지는 바이러스 백신을 제조하기 위한 조성물 및 방법 |
| CN121816361A (zh) | 2023-04-26 | 2026-04-07 | 国立健康危机管理研究机构 | 抗流感抗体 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2374894B1 (en) * | 1993-09-13 | 2014-09-17 | Protein Sciences Corporation | A method for producing influenza hemagglutinin multivalent vaccines |
| US8278083B2 (en) | 2004-03-22 | 2012-10-02 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Inactivated influenza virus compositions |
| US20230201329A1 (en) * | 2006-07-17 | 2023-06-29 | Glaxosmithkline Biologicals Sa | Influenza vaccine |
| US20090181078A1 (en) * | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
| JPWO2008114819A1 (ja) | 2007-03-20 | 2010-07-08 | 大日本住友製薬株式会社 | 新規アデニン化合物 |
| PE20090146A1 (es) * | 2007-04-20 | 2009-03-23 | Glaxosmithkline Biolog Sa | Composicion inmunogenica contra el virus influenza |
| JP5518041B2 (ja) * | 2008-03-18 | 2014-06-11 | ノバルティス アーゲー | インフルエンザウイルスワクチン抗原の調製における改良 |
| CA2731686C (en) | 2008-07-25 | 2020-04-07 | Institute For Research In Biomedicine | Neutralizing anti-influenza a virus antibodies and uses thereof |
| WO2010047509A2 (ko) | 2008-10-24 | 2010-04-29 | 아주대학교 산학협력단 | 친화도와 안정성이 향상된 항 ｄｒ5 항체, 및 이를 포함하는 암 예방 또는 치료용 조성물 |
| CN102223895B (zh) * | 2008-11-25 | 2014-11-05 | 巴克斯特保健股份有限公司 | 生产pH稳定的包膜病毒的方法 |
| CN101524538A (zh) | 2009-03-26 | 2009-09-09 | 成都康华生物制品有限公司 | 一种流感-大流行流感二价联合疫苗及其制备方法 |
| EP2536425B1 (en) | 2010-02-18 | 2019-06-19 | Icahn School of Medicine at Mount Sinai | Vaccines for use in the prophylaxis and treatment of influenza virus disease |
| EP3098236A1 (en) | 2010-03-08 | 2016-11-30 | Celltrion, Inc. | Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses |
| CN102939103A (zh) | 2010-03-30 | 2013-02-20 | 西奈山医学院 | 流感病毒疫苗及其应用 |
| BR112013025254A2 (pt) | 2011-04-21 | 2016-09-06 | Baxter Internat Inc E Baxter Healthcare S A | método para isolar um antígeno de uma composição de vacina |
| CN102406931B (zh) * | 2011-11-25 | 2014-02-05 | 成都康华生物制品有限公司 | 大流行流感病毒裂解疫苗 |
| WO2013173256A2 (en) * | 2012-05-16 | 2013-11-21 | Kj Biosciences, Llc | New and improved influenza vaccines |
| KR20140118682A (ko) | 2013-03-29 | 2014-10-08 | (주)셀트리온 | 2 이상의 인플루엔자 ａ 바이러스 중화 결합 분자를 포함하는 조성물 |
| AU2015305690A1 (en) | 2014-08-18 | 2017-03-02 | Sanofi Pasteur Inc. | Alkylated influenza vaccines |
| US11191727B2 (en) | 2014-12-31 | 2021-12-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Multivalent nanoparticle-based vaccines |
| JP2018517405A (ja) * | 2015-05-04 | 2018-07-05 | エピバックス インコーポレーテッド | インフルエンザａ／上海／２／２０１３ ｈ７配列の改変ｈ７赤血球凝集素糖タンパク質 |
| CN108348618B (zh) * | 2015-09-29 | 2021-06-15 | 大日本住友制药株式会社 | 腺嘌呤缀合物化合物及其作为疫苗佐剂的用途 |
| EP3603619B1 (en) * | 2017-03-29 | 2025-08-13 | Sumitomo Pharma Co., Ltd. | Vaccine adjuvant formulation |
| WO2019045090A1 (ja) * | 2017-09-04 | 2019-03-07 | 公益財団法人ヒューマンサイエンス振興財団 | インフルエンザｈａスプリットワクチンの製造方法 |
| JP7403733B2 (ja) | 2017-09-04 | 2023-12-25 | 国立感染症研究所長 | インフルエンザｈａスプリットワクチンの製造方法 |
| CA3107409A1 (en) | 2018-07-23 | 2020-01-30 | Japan As Represented By Director General Of National Institute Of Infectious Diseases | Composition containing influenza vaccine |
| CA3121613A1 (en) * | 2018-12-26 | 2020-07-02 | Sumitomo Dainippon Pharma Co., Ltd. | Preparation including vaccine adjuvant |
| JP2022521760A (ja) * | 2019-02-28 | 2022-04-12 | ノババックス，インコーポレイテッド | Ｒｓｖ感染によって引き起こされる疾患又は障害を予防する方法 |
-
2020
- 2020-03-03 EA EA202192398A patent/EA202192398A1/ru unknown
- 2020-03-03 AU AU2020233456A patent/AU2020233456B2/en active Active
- 2020-03-03 BR BR112021017310A patent/BR112021017310A8/pt unknown
- 2020-03-03 US US17/435,590 patent/US12491240B2/en active Active
- 2020-03-03 CA CA3132578A patent/CA3132578A1/en active Pending
- 2020-03-03 KR KR1020217030986A patent/KR20210135261A/ko active Pending
- 2020-03-03 CN CN202080033434.5A patent/CN114096273B/zh active Active
- 2020-03-03 SG SG11202109566X patent/SG11202109566XA/en unknown
- 2020-03-03 MX MX2021010685A patent/MX2021010685A/es unknown
- 2020-03-03 EP EP20766488.9A patent/EP3936147A4/en active Pending
- 2020-03-03 PH PH1/2021/552094A patent/PH12021552094A1/en unknown
- 2020-03-03 MY MYPI2021005035A patent/MY208974A/en unknown
- 2020-03-03 WO PCT/JP2020/008974 patent/WO2020179797A1/ja not_active Ceased
- 2020-03-03 JP JP2021504119A patent/JP7545955B2/ja active Active
-
2021
- 2021-08-31 IL IL285984A patent/IL285984A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020179797A5 (https=) | ||
| Lu et al. | Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F (ab') 2 in mice | |
| Thérien et al. | A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling | |
| NZ511918A (en) | Flu vaccine comprising four synthetic peptide epitopes | |
| JP2009225809A5 (https=) | ||
| JP2014500013A5 (https=) | ||
| Ravin et al. | Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein | |
| US10881723B2 (en) | Vaccine containing immobilized virus particles | |
| US11732031B2 (en) | Method for producing influenza HA split vaccine | |
| US10912825B2 (en) | Influenza vaccines | |
| CN105838678A (zh) | 一种分泌cpiv3抗体的杂交瘤细胞株及elisa试剂盒 | |
| JP2019043937A5 (https=) | ||
| JP7545955B2 (ja) | インフルエンザｈａスプリットワクチンの製造方法 | |
| JP2011201913A (ja) | Ｉｐｖ−ｄｐｔワクチン | |
| CN115768799A (zh) | 抗her2单克隆抗体冻干制剂及制备方法 | |
| WO2000020565A1 (en) | Enhanced immunogen for inactivated vaccine for infection with japanese encephalitis viruses and process for producing the same | |
| CN116410899A (zh) | 利用裂解酶LysP53产生细菌外膜囊泡的方法及应用 | |
| JPWO2016010081A1 (ja) | ウイルス様粒子を含むワクチン | |
| WO2019045090A1 (ja) | インフルエンザｈａスプリットワクチンの製造方法 | |
| CN112877300A (zh) | 一种g4型欧亚类禽h1n1猪流感病毒灭活疫苗的制备 | |
| CN101594881B (zh) | 吸附灭活流感疫苗及其制备方法 | |
| US11633469B2 (en) | Reassortant influenza virus production method | |
| CN119751663B (zh) | 一种抗流感病毒np蛋白中和纳米抗体及其应用 | |
| Liu et al. | Rabbit anti-rabies immunoglobulins production and evaluation | |
| CN1136010C (zh) | 亚单位抗原微乳剂疫苗的制造方法 |